As General Study Manager, you enable global hematology studies in collaboration with AstraZeneca, ensuring timely delivery, budget discipline, and high quality. You work within ICON’s FSP team to integrate with client operations and external vendors, driving study setup, execution, and close-out. You’ll contribute to risk management, QA, and inspection readiness, shaping study documentation and regulatory compliance. This role offers impact through cross‑functional partnerships and a focus on early‑phase hematology/oncology studies.